Suchergebnisse - "Rimassa, Lorenza"

PubPharm (370)

61

Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice : Results of the AB-real study

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Fulgenzi, C. | Cheon, J. | D'Alessio, A. | +34

62

What is the gender representation in authorship in later phase systemic clinical trials in biliary tract cancer (BTC)? - a retrospective review of the published literature

enthalten in: BMJ open | 2022

von McNamara, M. | Bridgewater, J. | Goyal, L. | +15

63

Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis : A real-world study

enthalten in: Hepatology (Baltimore, Md.) | 2022

von D'Alessio, A. | Fulgenzi, C. | Nishida, N. | +32

CommentIn: Hepatology. 2022 Oct;76(4):906-908. - PMID 35491442

64

Determinants of Treatment Benefit and Post-Treatment Survival for Patients with Hepatocellular Carcinoma Enrolled in Second-Line Trials after the Failure of Sorafenib Treatment

enthalten in: Journal of personalized medicine | 2022

von Personeni, N. | Pressiani, T. | Zanuso, V. | +10

65

Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas : An Early Exploratory Analysis

enthalten in: Targeted oncology | 2022

von Rimini, M. | Burgio, V. | Antonuzzo, L. | +13

66

Functional Investigation of the Tumoural Heterogeneity of Intrahepatic Cholangiocarcinoma by In Vivo PET-CT Navigation : A Proof-of-Concept Study

enthalten in: Journal of clinical medicine | 2022

von Viganò, L. | Lopci, E. | Di Tommaso, L. | +7

67

Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis

enthalten in: Targeted oncology | 2022

von Rimini, M. | Burgio, V. | Antonuzzo, L. | +13

68

Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis

enthalten in: Targeted oncology | 2022

von Rimini, M. | Burgio, V. | Antonuzzo, L. | +13

69

Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis

enthalten in: Targeted oncology | 2022

von Rimini, M. | Burgio, V. | Antonuzzo, L. | +13

70

T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma

enthalten in: Journal of hepatology | 2022

von Barsch, M. | Salié, H. | Schlaak, A. | +30